Trial intelligence / Profile preview

Prucalopride in Pediatric Functional Constipation

NCT04759833Phase 3Terminated

Sponsor
Takeda
Start
Jul 2021
Primary completion
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of prucalopride in functional constipation (FC), sponsored by Takeda. Started Jul 2021; status: terminated.

02

Drugs

prucalopride
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on NCT04759833.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04759833.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call